Filing Details
AVANOS MEDICAL, INC. (NYSE:AVNS) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNYSE:AVNS
AVANOS MEDICAL, INC. (AVNS) Reports Material Event to SEC
Filing Details AVANOS MEDICAL, INC. (NYSE:AVNS) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context AVANOS…
Market Context
AVANOS MEDICAL, INC.'s stock currently trades at $24.93 with a market capitalization of $549.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for AVANOS MEDICAL, INC.'s stock.
All SEC filings for AVANOS MEDICAL, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AVNS Stock Page
Frequently Asked Questions
Where can I read AVNS's SEC filings?
Browse all filings on our AVNS SEC filings page.
What types of SEC filings does AVANOS MEDICAL, INC. file?
Public companies like AVANOS MEDICAL, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
